Concepts basic to pharmacokinetics.

[1]  J S Harmatz,et al.  Diazepam disposition determinants , 1980, Clinical pharmacology and therapeutics.

[2]  S Oie,et al.  Effect of altered plasma protein binding on apparent volume of distribution. , 1979, Journal of pharmaceutical sciences.

[3]  F. Sjöqvist,et al.  Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. , 1978, The New England journal of medicine.

[4]  J. Tillement,et al.  Diseases and Drug Protein Binding , 1978, Clinical pharmacokinetics.

[5]  O. Borgå,et al.  Plasma protein binding of basic drugs , 1977 .

[6]  C. von Bahr,et al.  Effect of pentobarbital on the disposition of alprenolol , 1977, Clinical pharmacology and therapeutics.

[7]  K. Bachmann,et al.  Protein Binding of Coumarin Anticoagulants in Disease States , 1977, Clinical pharmacokinetics.

[8]  N. Benowitz,et al.  Pharmacokinetics in Patients with Cardiac Failure , 1976, Clinical pharmacokinetics.

[9]  R. Branch,et al.  A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol. , 1976, British Journal of Clinical Pharmacology.

[10]  G. Wilkinson,et al.  Effects of route of administration and blood flow on hepatic drug elimination. , 1975, The Journal of pharmacology and experimental therapeutics.

[11]  Grant R. Wilkinson,et al.  A physiological approach to hepatic drug clearance , 1975 .

[12]  U. Klotz,et al.  The effects of age and liver disease on the disposition and elimination of diazepam in adult man. , 1975, The Journal of clinical investigation.

[13]  A. Yacobi,et al.  Letter: Effect of plasma protein binding on elimination of warfarin. , 1974, Journal of pharmaceutical sciences.

[14]  R. Branch,et al.  Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow. , 1974, The Journal of clinical investigation.

[15]  R. Branch,et al.  The disposition of propranolol. 8. General implications of the effects of liver blood flow on elimination from the perfused rat liver. , 1973, Drug metabolism and disposition: the biological fate of chemicals.

[16]  D. Shand,et al.  The hemodynamic effects of beta adrenergic blockade on the flow-dependent hepatic clearance of propranolol. , 1973, The Journal of pharmacology and experimental therapeutics.

[17]  S. S. Schreiber,et al.  Albumin synthesis. 1. , 1972, The New England journal of medicine.

[18]  T. Blaschke.  Protein Binding and Kinetics of Drugs in Liver Diseases , 1977, Clinical pharmacokinetics.

[19]  G. Wilkinson,et al.  Altered Hepatic Blood Flow and Drug Disposition , 1976, Clinical pharmacokinetics.

[20]  W J Jusko,et al.  Plasma and tissue protein binding of drugs in pharmacokinetics. , 1976, Drug metabolism reviews.

[21]  U. Klotz,et al.  Pathophysiological and Disease-Induced Changes in Drug Distribution Volume: Pharmacokinetic Implications , 1976, Clinical pharmacokinetics.

[22]  R. Gugler,et al.  Drug Protein Binding and the Nephrotic Syndrome , 1976, Clinical pharmacokinetics.

[23]  G. Wilkinson.  Pharmacokinetics of drug disposition: hemodynamic considerations. , 1975, Annual review of pharmacology.

[24]  M. Rowland,et al.  Influence of route of administration on drug availability. , 1972, Journal of pharmaceutical sciences.

[25]  J. G. Hoffman,et al.  Physical Techniques in Biological Research , 1963 .

[26]  M. Gregersen,et al.  CHAPTER 1 – DETERMINATION OF BODY FLUID VOLUMES , 1962 .